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Introduction
!
The integration of detection, characterization, di-
agnosis, and staging at the time of endoscopy is
still an unmet clinical need. The advent of biopho-
tonics in endoscopy has opened new horizons
and created important new opportunities for the
enhanced identification and biochemical charac-
terization of disease.
A number of biophotonic techniques are currently
being investigated owing to their potential to ac-
quire biochemical information noninvasively and
to image with subcellular resolution beyond
what is possible with currently available tech-
niques; however, the published experience is lim-
ited [1].
Point spectroscopy with probes inserted through
the working channels of conventional endoscopes
has been able to differentiate non-neoplastic from
neoplastic tissues and to examine the biochem-
ical environment of diseased tissue. Alterations
in autofluorescence spectra reflect changes in
the molecular composition and biochemical en-
vironment of diseased tissue. Some examples of
studies of gastrointestinal disease with the use of
diffuse reflectance spectroscopy (DRS), which de-
tects changes in the physical properties of cells,
include the in vivo detection of dysplasia in colon
polyps [2] and Barrett’s esophagus [3,4], and re-
cently, near-infrared diffuse reflectance imaging
has also been applied ex vivo to surgical speci-
mens of colon cancer [5].
A further development is fluorescence lifetime
imaging microscopy, often referred to as FLIM or
autofluorescence, which offers the potential to
improve overall diagnostic accuracy by providing
label-free quantitative contrast [6,7]. Optical co-
herence tomography (OCT) allows imaging at
greater depths within tissue in comparison with
confocal laser endomicroscopy (CLE) but does
not normally supply functional information. Ra-
man spectroscopy and coherent anti-Stokes Ra-
man scattering (CARS) microscopy can be used to
obtain highly detailed spectroscopic information
but usually require long data acquisition times
and cannot be readily extended to provide a
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Detection, characterization, and staging consti-
tute the fundamental elements in the endoscopic
diagnosis of gastrointestinal diseases, but histolo-
gy still remains the diagnostic gold standard.
New developments in endoscopic techniquesmay
challenge histopathology in the near future. An
ideal endoscopic technique should combine a
wide-field, “red flag” screening technique with
an optical contrast or microscopy method for
characterization and staging, all simultaneously
available during the procedure. In theory, biopho-
tonic advances have the potential to unite these
elements to allow in vivo “optical biopsy.”
These techniques may ultimately offer the poten-
tial to increase the rates of detection of high risk
lesions and the ability to target biopsies and re-
sections, and so reduce the need for biopsy, costs,
and uncertainty for patients. However, their utili-
ty and sensitivity in clinical practice must be eval-
uated against those of conventional histopatholo-
gy.
This review describes some of themost recent ap-
plications of biophotonics in endoscopic optical
imaging and metrology, along with their funda-
mental principles and the clinical experience
that has been acquired in their deployment as
tools for the endoscopist. Particular emphasis
has been placed on translational label-free optical
techniques, such as fluorescence spectroscopy,
fluorescence lifetime imaging microscopy (FLIM),
two-photon and multi-photon microscopy, sec-
ond harmonic generation (SHG) and third harmo-
nic generation (THG) imaging, optical coherence
tomography (OCT), diffuse reflectance, Raman
spectroscopy, and molecular imaging.
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wide-field screening tool that can image fields of view of several
centimeters. An alternative to intrinsic optical signals is the use of
exogenous labels, such as labeled monoclonal antibodies against
the carcinoembryonic antigen (CEA), or the epidermal growth
factor receptor (EGFR), or photosensitizers administered topical-
ly. These markers can then be imaged with a range of instru-
ments, such as confocal endomicroscopy or prototype fluores-
cence endoscopes [8–10]. These techniques are generally re-
ferred as to molecular imaging. However, most of these diagnos-
tic applications are still in the early stage of development.
Biophotonics is a relatively novel, interdisciplinary science that
uses light-based technology to image, detect, and characterize
the interplay between light and biological materials, including
cells and tissues in living organisms.
When light reaches the surface of a tissue, it may either be direct-
ly reflected or enter the tissue. Light is scatteredwithin the tissue
owing to small differences in the refractive index caused by cell
nuclei and cell organelles. It may then exit the tissue surface as
diffusely reflected light or be absorbed by molecules within the
tissue. If the light is absorbed, it may be converted to fluores-
cence. This fluorescence light is again scattered within the tissue
and may be reabsorbed by another molecule or may exit the tis-
sue.
Thus, based on this complex interaction, biophotonic techniques
can be classified mainly as scattering or fluorescence-based. This
classification also takes into account the excitation wavelength
used to actualize the process (ultraviolet- visible vs. near-infra-
red spectrum).
It is difficult at present to classify each method according to its
potential clinical use and according to what diseases it is best ap-
plied because different modalities might be used for one or all
elements of diagnosis and be applied to a variety of different con-
ditions. Although individual techniques aim to prove useful for a
specific aspect of the diagnostic process, there is some cluster
overlap between the elements, as shown in the stylized Venn dia-
gram in●" Fig.1.
The most appropriate and useful method for classifying biopho-
tonic endoscopic techniques is probably according to their ability
to provide functional and biochemical information and/or to en-
hance spatial resolution. In order to present some of the relevant
features of each technique in a graphic form, we have placed each
modality on a two-dimensional grid where the axes are spatial
resolution and amount of functional information (●" Fig.2). How-
ever, it should be noted that with further development, some
techniques, such as FLIM, molecular imaging, and OCT, may be
able to offer both functions either individually or combined.
Ultimately, in terms of the propagation of light into tissue and ax-
ial resolution, they can be further classified as up to or beyond
1000 μm (●" Table1).
The following sections review the fundamental principles of and
clinical experiencewith themost recent translational biophoton-
ic modalities, which may offer improved image resolution, con-
trast, and tissue penetration and may report on biochemical and
molecular changes beyond the discrimination of existing endo-
scopic methods.
A glossary of key terms and definitions appears in●" Table2 to
clarify the terminology used throughout this review.
Techniques providing functional/biochemical
information
!
Fluorescence spectroscopy and lifetime imaging
Fluorescence is defined as the emission of light by a medium
(e.g., tissue) that has absorbed light of a different wavelength. In
most cases, the emitted light has a longer wavelength, and there-
fore a lower energy level, than the absorbed light. Fluorescence
can use endogenous (autofluorescence) or exogenous fluoro-
phores (i. e., fluorescein) to achieve contrast and distinguish be-
tween normal and diseased tissue, based on specific molecular
characteristics of the tissue. Particularly, autofluorescence is gen-
erated by intra- and extracellular endogenous fluorophores, such
as collagen, elastin, and pyridine nucleotides, and the distribu-
tion of these fluorophores can be different in normal and dis-
eased tissue.
However, intensity-based autofluorescence contrast is often not
sufficiently specific because it is difficult to make quantitative in-
tensity measurements. Therefore, when the autofluorescence of
biological tissue is studied, the molecular composition is often
unknown, and so tissue autofluorescence can present a complex
Characterization
Detection
Molecular
imaging
MPMSHG
OCT
CARS
Staging
Raman
imaging
FLIM
fa/LCIDRS
FLS
Raman
spectroscopy
Fig.1 Stylized Venn diagram showing predominant targets and potential
relationships/overlaps between different biophotonic techniques in de-
tecting, characterizing, and staging diseases at endoscopy. DRS, diffuse
reflectance spectroscopy; fa/LCI, frequency-domain angle-resolved low
coherence interferometry; FLIM, fluorescence lifetime imaging microsco-
py; FLS, fluorescence lifetime spectroscopy; SHG, second harmonic gen-
eration; MPM, multiphoton microscopy; OCT, optical coherence tomog-
raphy; CARS, coherent anti-Stokes Raman scattering.
Spatial resolution
Functional information
fa/LCI
Raman spectroscopy Raman imaging
FLIM
MPM
CARS
SHGOCT
Molecular imaging
FLS
DRS
Fig.2 Two-dimensional grid-based classification of biophotonic tech-
niques according to their ability to provide functional information and/or to
enhance spatial resolution. fa/LCI, frequency-domain angle-resolved low
coherence interferometry; FLS, fluorescence lifetime spectroscopy; DRS,
diffuse reflectance spectroscopy; FLIM, fluorescence lifetime imaging mi-
croscopy; MPM, multiphoton microscopy; CARS, coherent anti-Stokes Ra-
man scattering; OCT, optical coherence tomography; SHG, second har-
monic generation.
Coda Sergio et al. Biophotonic endoscopy for clinical research in early gastrointestinal cancer… Endoscopy International Open
Review
THIEME
D
ow
nl
oa
de
d 
by
: I
P-
Pr
ox
y 
CO
NS
O
RT
IU
M
:S
W
ET
SS
TA
TS
 (Im
pe
ria
l C
oll
eg
e),
 Im
pe
ria
l C
oll
eg
e L
on
do
n. 
Co
py
rig
hte
d m
ate
ria
l.
signal resulting from an unknown number of endogenous fluor-
ophores present in unknown relative concentrations. The inter-
pretation of autofluorescence data is therefore highly challen-
ging, typically requiring a priori knowledge of tissue structure
and/or physiologic function to yield quantitative information.
Fluorescence lifetime
Fluorophores are molecules within tissue that spontaneously
emit light when illuminated by light at appropriate wavelengths.
When these molecules are illuminated, they can absorb energy
from the incident photons, and an electron within the molecule
may enter an excited state. Following light absorption, a fluoro-
phore will remain in an excited electronic energy state for a very
short period of time before returning to its ground state via the
emission of fluorescent light, in a manner somewhat similar to
the radioactive decay of an unstable atom.
A fluorophore in the excited electronic state may also return to
the ground state by a number of nonradiative processes (i.e.,
without the emission of fluorescence). Thus, fluorescent light
from a sample does not instantaneously cease the moment that
the excitation light is extinguished; rather, it decays away over a
period of nanoseconds as excited fluorophore molecules in the
sample return to their ground state. This period is referred to as
fluorescence lifetime (τ), and the energy transfer is schematically
illustrated with the classic Jablonski diagram (●" Fig.3a). The key
point is that different fluorophores decay at different rates, and
this parameter can be mapped at every pixel in an image in order
to produce a fluorescence lifetime image (●" Fig.3b). Typical
fluorescence lifetimes are of the order of picoseconds (10‑12 sec-
onds) to nanoseconds (10‑9 seconds).
FLIM is a powerful means to map the decay rate of fluorescence
emitted from tissue samples, providing quantitative contrast. It
can be achieved for a variety of fluorescence imaging instru-
ments, including wide-field imaging, confocal microscopy, and
two-photon microscopy.
Optical fiber probe-based fluorescence lifetime spectroscopy
(FLS) can resolve the fluorescence emission spectrum and fluor-
escence decay rate to provide a wealth of label-free (i. e., no need
for external contrast agents) information from biological tissue.
The lifetime of a fluorophore depends on the rate of decay from
the excited electronic state back to the ground state by both ra-
diative (Γ) and nonradiative (κ) means (●" Eq. 1):
The radiative decay rate (Γ) is essentially a function of the fluoro-
phore and is relatively unaffected by its surrounding environ-
ment. Conversely, the nonradiative decay rate (κ) depends on
the local physicochemical environment of the fluorophore. It
may be sensitive to a number of different parameters, such as
viscosity, temperature, pH, and oxygen concentration, as all these
factors may influence the intermolecular events that account for
the nonradiative transition of an excited fluorophore to its
ground state. Therefore, fluorescence lifetime can be influenced
by, and so can be used as an indicator of, a certain fluorophore’s
local environment. Thus, the measurement of temporally re-
solved fluorescence affords the possibility of obtaining functional
as well as structural information.
Another important characteristic of the fluorescence lifetime is
that it is an inherently ratiometric quantity because it depends
Table 2 Glossary of key terms and definitions in biophotonics.
Biophotonics Novel interdisciplinary science using light-based
technology to image, detect, and characterize the in-
terplay between light (photons) and biological mate-
rials, including cells and tissues in living organisms.
Biophotonic Of or pertaining to biophotonics.
Label-free Defines detection methods not requiring the admin-
istration of external agents to achieve contrast.
Metrology Science studying, defining, and investigating meas-
urements (e. g., spectra) but not imaging phenom-
ena.
Spectroscopy Science investigating and measuring spectra resulting
from the interaction of light and matter (e. g., biolo-
gical tissue).
Fluorescent
probes
External molecules (e. g., contrast agents or drugs)
capable of absorbing light of a specific wavelength
and emitting light of a different, typically longer wa-
velength to produce visible and measurable fluores-
cence.
Scattering Deflection or diffusion of light resulting from interac-
tion of the incident beam with a substance but not in-
volving fluorescence (no absorption occurs).
Fluorescence Emission of light by a substance that has absorbed
light.
Table 1 Summary of emerging biophotonic techniques in endoscopy.
Technique Func-
tion
Morphol-
ogy
Cross-sec-
tionable
Maximum
depth, μm
Excitation, λ Acquisition
time, s
Clinical
experience
References
OCT N Y Y 4000 Near-IR 1.5 Ex vivo, in vivo 48–62
FLIM Y Y Y (confocal) < 100 UV-blue 20–120 Ex vivo, in vivo 1,6,7,19,78,82
FLS Y N N <100 UV-blue < 15 Ex vivo, in vivo 6,14,15
Raman
spectroscopy Y N N >1000 Near-IR 0.1–5 Ex vivo, in vivo 26–28
Raman imaging Y Y N <100 Near-IR > 1800 Ex vivo 72
DRS N N N <1000 White light 0.5 Ex vivo, in vivo 2,3,5,34 –38
MPM Y Y Y <2000 Near-IR 1 Ex vivo 66–70
SHG Y Y Y 100–300 Near-IR 1 Ex vivo 71
CARS Y Y N >1000 Near-IR 5.4 Ex vivo 72–74
fa/LCI N Y N <150 Near-IR < 1 Ex vivo 39,40
Molecular imaging Y Y Y (confocal) > 1000 Blue, near-IR1 2 Ex vivo 8–10,41–47
OCT, optical coherence tomography; FLIM, fluorescence lifetime imaging microscopy; FLS, fluorescence lifetime spectroscopy; DRS, diffuse reflectance spectroscopy;
MPM, multiphoton microscopy; SHG, second harmonic generation; fa/LCI, frequency-domain angle-resolved low coherence interferometry; near-IR , near-infrared.
1 Dependent on fluorescent label.
2 Dependent on technique used.
τ ¼ 1Γþκ Eq:1
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on the intensity decay as a function of time and not on the abso-
lute intensity. As such, unlike measurements with the intensity
signal alone (e.g., standard autofluorescence), measurements of
the fluorescence lifetime do not suffer from uncertainties due to
variations in fluorophore concentration or excitation power. For
this reason, considerable research efforts have been directed to-
ward the development of instruments for time-resolved fluores-
cence spectroscopy and imaging. Most importantly, the fluores-
cence lifetime has been shown to help discriminate between
healthy and diseased tissue [7,11–17].
Measurement of fluorescence lifetimes
There are two main ways of performing FLIM: time domain and
frequency domain.
Fluorescence lifetime in the time domain is measured by record-
ing the intensity decay of fluorescence after excitation with a
very short pulse of light. It can be done either by time gating
(●" Fig.4), as is used in wide-field microscopes, or by time-cor-
related single-photon counting (TCSPC), as is used in confocal mi-
croscopes and spectroscopy systems (●" Fig.5). Time domain
measurements are the most intuitive because they involve direct
measurement of the decay of fluorescence intensity over time.
Frequency domain FLIM uses sinusoidally varying excitation
light. The resultant fluorescence is then also sinusoidally modu-
lated, but with a reduction in the modulation depth (and average
intensity) and a shift in phase (●" Fig.6).
Instrument response function
When a fluorescence decay measurement is performed, it should
be noted that the signal received depends not only on the sample
being analyzed but also on the response of themeasuring system.
These factors combine to form an instrument response function
that must be taken into account when fitting fluorescence de-
cays. The method used to obtain the instrument response func-
tion depends on the system being used, but it usually involves
measuring the time response of a fluorophore with a short life-
time (e.g., erythrosin B, daspi) or a scatterer (e.g., Ludox).
Displaying fluorescence lifetime imaging microscopy
(FLIM) images
Once a decay model has been fitted to every pixel within an im-
age, it is then necessary to display the data in an accessible and
informative manner. The most straightforward way to do this is
to make a false-color image. In this manner an 8-bit color image
is formed inwhich typically blue represents shorter lifetimes and
red is for longer lifetimes, corresponding to a lifetime scale speci-
fied by the user. This display strategy takes no account of intensi-
ty, and therefore some important structural information may be
lost; this may be remedied by merging the FLIM map with the
integrated intensity image. In this way, the structural informa-
tion is maintained, and pixels with low signals, which may have
less accurate lifetime fits, are given less emphasis. Images are
merged in LabVIEW (National Instruments, Austin, Texas, USA).
An example of a FLIM map, intensity image, and merge is shown
in●" Fig.7.
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Fig.4 The principle of time-gated detection for fluorescence lifetime
imaging microscopy (FLIM). The excitation light pulse is shown in purple,
with the fluorescence emission in green. Three detection time gates (t1, t2,
and t3) are also shown.
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Fig.3 a Jablonski diagram showing electronic energy levels of ground (E0)
and excited (E1) states and both radiative (Γ) and nonradiative (κ) decay
pathways in a fluorescent molecule. b After a short pulse of light, fluores-
cence emitted from the sample decays away over a period of nanoseconds
as excited molecules return to their ground state. Fluorescence lifetime
imaging microscopy (FLIM) produces images by using the fluorescence
lifetime determined at each pixel to provide image contrast, displayed
through a false-color scale, between tissues or different components
within the tissue that have different fluorescence decays.
Fluorescence
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Fig.5 Schematic diagram of the time-correlated
single-photon counting (TCSPC) acquisition proce-
dure. When a fluorescence photon is detected, ty-
pically by a photomultiplier tube, an electronic sig-
nal is sent to a time-to-amplitude converter (TAC),
which starts to linearly charge a capacitor; the
charging is subsequently stopped when the laser
next emits a light pulse. The charge on the capaci-
tor is then fed into an analogue-to-digital converter
(ADC) and the time recorded in memory. Repetition
of this process for many detected photons allows a
histogram of photon arrival times to be built up,
and decay models can then be fitted to these data.
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Clinical experience
Time-resolved autofluorescence spectroscopy in the gastrointes-
tinal tract was pioneered byMycek et al. [11]; this in vivo study of
24 polyps (13 adenomas, 11 non-adenomas) from 17 patients
used an excitation wavelength of 337nm and detection in the
range 530 to 570nm and demonstrated shorter average lifetimes
for neoplastic polyps (adenomas) than for non-neoplastic polyps
(9300±400 vs. 10500±700 picoseconds). This was the first study
in the colon that demonstrated differences in fluorescence life-
time decay between nondysplastic and dysplastic tissue. The
shift in fluorescence lifetime made it possible to distinguish
between the two tissue types investigated with a sensitivity of
85%, a specificity of 91%, a positive predictive value of 92%, and
a negative predictive value of 83%.
In work by Li et al. in ex vivo tissue, longer autofluorescence life-
times were found in cancerous colonic tissues than in normal co-
lon (18450 vs. 4320 picoseconds) with excitation at 397nm and
detection at 635nm. This was attributed to the contribution of
protoporphyrin IX (PpIX), which is known both to accumulate in
neoplasia and to have a long fluorescence lifetime [18].
With the use of wide-field FLIM, statistically significant auto-
fluorescence lifetime contrast was observed between cancerous
and healthy colon tissue in a series of 16 unstained surgical speci-
mens of colon cancer. In this study, the mean lifetime of auto-
fluorescence from neoplastic tissue induced by 355-nm ultravio-
let excitation was longer than autofluorescence from surround-
ing non-neoplastic tissue (3700±1100 vs. 3200±420 picose-
conds) [7]. Autofluorescence lifetime contrast between cancer-
ous and healthy tissue was also shown in a specimen of unfixed
ex vivo liver containingmetastatic colorectal carcinoma and in an
unfixed pancreas containing an area of pancreatic adenocarcino-
ma.
Preliminary data from our group have shown a statistically signif-
icant decrease in 435-nm excited, spectrally averaged mean
fluorescence lifetime (mean Δτ=–570±740 picoseconds, P=
0.021) in a comparison between normal tissue and neoplastic co-
lonic polyps obtained from 12 patients undergoing colonoscopy
as part of their clinical investigation. The shift in spectrally aver-
aged mean fluorescence lifetime was found to be correlated with
the shift in the emission spectrum (r2=0.71). Although the differ-
ence in the spectrally averaged mean lifetime shift between neo-
plastic and non-neoplastic polyps was not found to be statistical-
ly significant, if the changes in mean autofluorescence lifetime
and emission wavelength of 435-nm excited fluorescence are
combined, then a discrimination of neoplastic from non-neoplas-
tic polyps with a sensitivity of 75% and a specificity of 83% is
achieved. This study was undertaken with a compact, clinically
compatible endoscopic fiberoptic coupled spectrofluorometer
(●" Fig.8) using all-solid-state picosecond diode lasers to provide
simultaneous measurements of time-resolved fluorescence spec-
tra with two excitation wavelengths (375 and 435nm) [15].
A current prospective in vivo study with the same FLS system is
under way to determine if the trends observed ex vivo are con-
firmed. Initial analysis has indicated that at 435-nm excitation,
polyps exhibit mean fluorescence lifetime values shorter than
those of normal tissue, and although no diagnostically significant
differences were observed in the signals obtained in vivo, these
data are consistent with our ex vivo measurements. When differ-
ent regions of endoscopically and histologically normal colon
(rectum, left and right colon) were compared with respect to
their spectrally averaged normalized emission spectrum and
mean fluorescence lifetime, statistically significant differences
were obtained for 375-nm excitation (P=0.0017), with the great-
est difference observed between right and left colon (P=0.001).
Pfefer et al. [12] used excitation wavelengths of 337nm and 400
nm and compared the measurement of fluorescence emission
spectra with fluorescence decay profiles acquired at 550nm in
vivo in 37 patients (17at 337nm and 20at 400nm) undergoing
routine endoscopic surveillance for Barrett’s esophagus. In this
study, time-resolved fluorescencewas unable to achieve sensitiv-
ity and specificity values above 60% for discriminating high risk
(carcinoma, high grade dysplasia) from low risk (low grade dys-
plasia, no dysplasia, or indefinite for dysplasia) tissue, whereas
moderate overall accuracy was achieved with steady-state fluor-
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Fig.6 Phase shift and demodulation seen in frequency domain fluores-
cence lifetime imaging microscopy (FLIM) during excitation with sinusoid-
ally modulated light. The phase shift (φ) is labeled, as are the amplitudes of
the excitation light (Aex) and emitted light (Aem) and the respective average
intensities (Iex and Iem).
Fig.7 Matched white light, fluorescence intensity, and fluorescence lifetime imaging microscopy (FLIM) images of a fresh hemicolectomy specimen con-
taining a moderately differentiated colonic adenocarcinoma. aWhite light image. b Fluorescence integrated intensity image. c False-color FLIM map.d FLIM
merge image showing clear visual contrast between areas of normal and malignant tissue. (Adapted and reproduced with permission from McGinty J,
Galletly NP, Dunsby C et al. Wide-field fluorescence lifetime imaging of cancer. Biomed Opt Express 2010; 1: 627–640 [7].)
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escence only (74% sensitivity, 67% specificity and 74% sensitivity,
85% specificity for 337-nm and 400-nm excitation, respectively).
Recently, Sun et al. developed and applied in vivo a clinically
compatible FLIM system consisting of a rigid fiber-bundle endo-
scope proving a field of view of 4mm. Intraoperative imaging of
head and neck squamous cell carcinomawas performed in 10 pa-
tients at 337-nm excitation and fluorescence collected in the
435- to 485-nm range with the intent of facilitating tumor mar-
gin demarcation. Head and neck squamous cell carcinoma exhib-
ited a shorter average lifetime (1210±40 picoseconds) than the
surrounding normal tissue (1490±60 picoseconds) [19].
Raman spectroscopy
Raman spectroscopy has been used to probe the biochemical sig-
natures of a multitude of biological molecules. The Raman effect
results from energy exchange between incident light and scatter-
ing molecules within tissue. It is also referred to as inelastic scat-
tering because Raman scattered light has less energy than the in-
cident light. Raman signals have typical narrow peaks that are
generally associated with the vibration of a particular chemical
bond in a molecule. As the bond stretches and shrinks, a shift in
frequency, which is characteristic of a particular molecule, is in-
dicated in the spectrum. Therefore, Raman spectroscopy can pro-
vide highly specific molecular fingerprint information that is
chemically sensitive and label-free. Raman spectroscopy can be
integrated with confocal microscopy for high spatial resolution.
However, Raman signals are usually weak (cross section typically
1000 times lower than fluorescence), and images require high la-
ser power (typically >10mW), ultrasensitive detectors, and long
acquisition times (>30 minutes), which are unsuitable for in vivo
clinical use.
Clinical experience
The feasibility of in vivo Raman spectroscopy for use in gastroin-
testinal endoscopy was first demonstrated in 2000 [20]. Raman
spectrawere obtained from various organs in the gastrointestinal
tract, including the esophagus and colon, during endoscopy with
a custom-built fiberoptic near-infrared Raman spectroscopic sys-
tem at 785-nm excitation, but because of the limited set of data,
only subtle differences were observed between normal and
pathologic states. Later on, distinctive in vivo Raman spectra
were shown by the same group in a comparison between 10 ade-
nomas and 9 hyperplastic colon polyps with 95% accuracy [21].
Principal component and linear discriminant analyses were
used to develop a diagnostic prediction model for classifying co-
lon polyps based on their spectral emission. Raman spectra were
also analyzed from 20 hyperplastic and 34 adenomatous polyps,
with accuracy (93%) similar to that of the in vivo measurements.
Microscopy-based Raman spectroscopy at 830-nm excitationwas
used to classify and discriminate between normal and pathologic
states, with a particular focus on early epithelial malignancies, in
a variety of organs, including larynx, esophagus, and bladder
[22]. Tissues were obtained during endoscopic or surgical proce-
dures and immediately snap-frozen. The histological assessment
preceded the spectral measurements, so that only samples with
clearly defined pathologies were measured. In the esophagus
study, Raman spectra were measured from 50 samples classified
in eight different tissue states: normal squamous epithelium, car-
diac Barrett’s esophagus, fundic Barrett’s esophagus, intestinal
metaplasia, high grade dysplasia, adenocarcinoma, squamous
dysplasia, and squamous cell carcinoma. No agreement was
achieved on samples with low grade dysplasia, so this group was
excluded from the analysis. Multivariate linear discriminant anal-
Fig.8 a Annotated photograph of the transportable trolley that houses the entire endoscopic spectrofluorometer, showing some important features of the
fiberoptic fluorescence lifetime spectroscopy (FLS) system developed by the Photonics Group at Imperial College London. b The custom-built fiber probe for
research use in gastrointestinal endoscopy (FiberTech GmbH, Berlin, Germany). c Annotated high-angle photograph illustrating the optical arrangement of the
time-resolved spectrofluorometer with the lid removed. PMT, photomultiplier tube; ND, neutral density. (Source of acquisition: Endoscopy Unit, Charing Cross
Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.)
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ysis was performed on the eight groups, and when the spectra
were combined into three clinically significant groups (normal,
Barrett’s esophagus, and Barrett’s esophagus neoplasia), 93.2%
and 88.6% of the cases were correctly predicted by the three-
and eight-group models, respectively. The development of a cus-
tom-built confocal Raman fiberoptic probe for endoscopic use
was then presented by the same group [23]. Raman spectra
were obtained from 58 esophageal biopsy specimens, and the
probe performance was compared with that of a conventional
spectrometer at both 2- and 10-second acquisition times.
Subsequent ex vivo work with the use of this probe at 830-nm
excitation in 72 esophageal samples from 35 patients, with acqui-
sition periods of 10 and 2 seconds, achieved a 73% overall correct
classification in spectrally separating histological diagnoses into
three clinically significant groups: normal, low risk (Barrett’s
esophagus), and high risk (dysplasia and cancer) [24]. Recent ex
vivowork with the probe in 298 fresh and 39 snap-frozen esoph-
ageal specimens, collected during surgery or endoscopy from 28
patients, confirmed the ability of this system to discriminate be-
tween Barrett’s esophagus and neoplasia with high levels of sen-
sitivity and specificity (88% and 87%, respectively) [25].
A follow-up study from the same group, of a larger number (673)
of ex vivo esophageal samples collected surgically and endoscop-
ically from 62 patients who had Barrett’s esophagus with a novel
endoscopic Raman probe, has confirmed the preliminary find-
ings, with similar sensitivity (86%) and specificity (88%) for de-
tecting high grade dysplasia and adenocarcinoma. Interestingly,
the potential for combination with narrow-band imaging was
also demonstrated [26].
Using a fiberoptic Raman endoscopy system under trimodal ima-
ging guidance (white light endoscopy [WLE]+narrow-band ima-
ging [NBI]+autofluorescence imaging [AFI]), an in vivo pilot
study was recently conducted in 27 patients with suspected
esophageal cancer [27]. Non-negativity constrained least squares
minimization (NNCLSM) biomolecular modeling and linear dis-
criminant analysis were used to develop a diagnostic algorithm
for separating normal esophageal mucosa from cancer with 97%
sensitivity and 95% specificity.
Impressively, the full potential of moving Raman spectroscopy
into real time during routine endoscopy has recently been rea-
lized in the context of a national gastric cancer screening pro-
gram in Singapore, where a large number of Raman spectra
(2465 normal and 283 gastric cancer) were acquired at 785-nm
excitation from 305 patients [28]. The algorithm analysis devel-
oped had modest overall diagnostic accuracy, but most impor-
tantly, the study showed that real-time acquisition per measure-
ment (<0.5 second) with a reasonably low power (1.5W/cm2) can
be achieved, which is critical for in vivo clinical applications.
Previous in vivo work published by the same group, combining
near-infrared autofluorescence and Raman spectroscopy, re-
vealed significant differences in both the spectral intensities and
Raman peaks of different colonic tissues, including normal colon
and hyperplastic and adenomatous polyps [29]. The intensities of
the adenomatous polyps were significantly lower than those of
the hyperplastic polyps and normal tissue (P<0.001). The spec-
tral shapes from different types of colonic tissues showed differ-
ent decreasing trends from 810 to 1050nm. Based on previous
experience [30], the authors assumed porphyrins to be the major
endogenous fluorophores responsible for near-infrared auto-
fluorescence emission in tissue, particularly in proliferative le-
sions [31]. Increased contents of porphyrins for the adenomatous
polyps in comparison with the hyperplastic polyps and normal
colonic tissue were found with the use of NNCLSM biochemical
modeling.
As anticipated in pioneering studies [21,32], with further devel-
opment this technique has the potential to distinguish adenomas
from hyperplastic or inflammatory colonic polyps, and low grade
from high grade dysplasia within Barrett’s esophagus, lesions
whose diagnosis still presents major challenges in gastrointesti-
nal pathology.
Diffuse reflectance spectroscopy
DRS, also known as elastic scattering spectroscopy (ESS), is used
to study the diffuse component of reflected light that has been
scatteredmultiple timeswithin the tissue sample to be investiga-
ted. A white light source, rather than a laser, is typically used to
illuminate the sample, and the reflected light is collected and
transmitted by optical fibers to the analyzing spectrometer. De-
livery and collection fibers are usually separated by a set distance
in order to allow the spectrometer to preferentially detect diffuse
(rather than specular) reflections. The resulting data then consist
of the diffuse reflectance of the sample as a function of wave-
length.
Because the propagation of light through a biological specimen
depends on its intrinsic absorptive and scattering properties,
the light elastically scattered can report on the architectural
changes associated with disease at both the cellular and subcellu-
lar level, such as cellular and nuclear enlargement and crowding
and an increased nucleus-to-cytoplasm ratio [33].
Clinical experience
Pioneering work with DRS was conducted by Mourant et al. in
1996 [34]. Reflectance spectra were taken in vivo from the colon
in 15 patients and from the stomach in 17 patients. The ratio of
the area under the reflectance curve between 540 and 580nm
to that under the reflectance curve between 400 and 420nm
was used to discriminate neoplastic from non-neoplastic colon
tissue. The slope of the spectrum in the 435- to 440-nm range
was used to reasonably separate active colitis from quiescent co-
litis and normal colonic mucosa. Gastric dysplasia was found in
only one case, and this was separated from normal and inflamed
gastric epithelium by using the ratio between 355 and 360nm to
that between 630 and 635nm. When multiple linear regression
was used for spectral classification, adenomatous polyps were
distinguished from hyperplastic polyps with a sensitivity of 89%
and a specificity of 75% [35].
Zonios et al. [2] collected diffuse reflectance spectra in vivo on
adenomatous polyps and adjacent normal colon in 13 patients
undergoing colonoscopy. Significant spectral differences were
observed, especially around 420nm (hemoglobin absorption val-
ley), and these were attributed to the increased hemoglobin con-
centration (six times higher) of polyps relative to that of normal
colon. In contrast, oxygen saturation was found to be similar in
both normal and adenomatous tissue.
Wallace et al. [36] measured diffuse reflectance spectra in 13 pa-
tients with a diagnosis of Barrett’s esophagus or suspected
esophageal cancer. The sites measured were subsequently ex-
cised and submitted for pathologic assessment. The data were
analyzed by a model in which a site was classified as dysplastic
if more than 30% of the nuclei were enlarged, with enlarged de-
fined as having a diameter greater than 10µm. Based on this
model, the samples were correctly classified with a high degree
of sensitivity and specificity (90% and 90%, respectively) for de-
tecting the presence of either high grade or low grade dysplasia.
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In a study by Lovat et al. [3], DRSmeasurements were collected in
vivo from 81 patients with high grade dysplasia or early cancer
within Barrett’s esophagus, then matched with histological spe-
cimens taken from identical sites within the segments of Bar-
rett’s esophagus. All biopsy specimens were reviewed by three
gastrointestinal pathologists and classified as low risk (no dys-
plasia or low grade dysplasia) or high risk (high grade dysplasia
or cancer). DRS detected high risk sites with a high sensitivity of
92%, but the specificity was only 60%. The specificity increased to
79% when ESSwas used to discriminate high risk sites from areas
of inflammation. In a concurrent study from the same group,
conducted in 45 patients undergoing colonoscopy, ESS was able
to discriminate with good accuracy among the different disease
groups investigated, including adenomatous from hyperplastic
polyps, cancer from adenomas, inflammatory bowel disease
(IBD) from normal colon, and dysplastic polyps from IBD [37].
Low coherence enhanced backscattering (LEBS) spectroscopy, a
variant of ESS, was recently proposed as an endoscopic prescre-
ening method for colorectal cancer screening. Based on the con-
cept of field carcinogenesis, micro-scale spectral changes were
measured in biopsy specimens of endoscopically normal rectum
obtained from 219 patients undergoing colonoscopy to predict
whether their colon harbored cancer or advanced adenomas
elsewhere [38]. LEBS-detectable alterations in endoscopically
normal rectum were seen to mirror neoplasia progression in pa-
tients with no neoplasia, 5- to 9-mm adenomas, and advanced
adenomas. For advanced adenomas, the LEBS signals had a sensi-
tivity of 100% and a specificity of 80%. Further studies with an
endoscopically compatible fiberoptic probe are under way for va-
lidation of these results in vivo.
Angle-resolved low coherence interferometry
Changes in the density and size of cell nuclei are considered char-
acteristic biomarkers of dysplasia. By analyzing the angular dis-
tribution of the backscattered light from a sample at different
depths, this technique enables the measurement of cellular and
nuclear morphology and offers the potential to assess cellular
structure and organization in vivo.
Pyhtila et al. [39] developed a probe-based frequency-domain
angle-resolved low coherence interferometry (fa/LCI) system
with a subsecond acquisition time to make depth-resolved (up
to 150µm) quantitative measurements of changes in the size
and texture of cell nuclei in tissue samples. Three esophageal spe-
cimens from three patients, who underwent esophagectomy for
Barrett’s neoplasia, were measured to examine the average nu-
clear size and density in healthy and dysplastic tissue, and the
findings were in complete concordance with histology.
In vivo results [40] reported sensitivity as high as 100% and spe-
cificity of 84% for the discrimination of dysplasia with a fiber
probe system for clinical fa/LCI (Oncoscope, Durham, North Caro-
lina, USA) in 46 patients undergoing routine surveillance for Bar-
rett’s esophagus.
Molecular imaging
Endoscopic molecular imaging with fluorescently labeled targe-
ted peptides is being increasingly investigated for the detection
of inconspicuous dysplasia or cancer [41,42].
Ito et al. [43] used an anti-CEA antibody tagged with a novel
fluorescent label (ICG-sulfo-OSu) and an infrared fluorescence
endoscope to stain and image freshly resected specimens of gas-
tric cancer from three patients. They found good correlation be-
tween the intensity of the infrared fluorescent signal and the
cancerous sites, suggesting that this technique can spot cancer
cells and generate a relatively strong fluorescent signal to detect
small cancers.
Keller et al. [8] conducted an in vivo study in 27 patients with co-
lonic polypoid lesions (8 adenomas, 25 carcinomas) by using a
fluorescein‑labeled antibody against CEA applied topically dur-
ing conventional endoscopy. Fluorescence emission was visualiz-
ed after 10 minutes of incubation with a standard fiberoptic
endoscope modified with a 490-nm narrow-band filter posi-
tioned at the light source and a special lens containing a built-in
520-nm narrow-band filter housed in the attached camera. Al-
though ulceration and bleeding proved to be limiting factors,
this approach led to high specificity (100%), modest sensitivity
(78.6%), and an overall diagnostic accuracy of 89.3%.
An indocyanine green-labeled antibody against the epithelial
membrane antigen (EMA) was developed by Muguruma et al.
[44]. This compound exhibited a specific fluorescence emission
at 807nm under infrared excitation (768nm) and was used to
stain paraffin sections of normal esophagus.
The use of molecular biomarkers in combination with confocal
endomicroscopy was first investigated by Hsiung et al. [45] to de-
velop a fluorescent probe for detecting colon cancer. They identi-
fied a specific heptapeptide sequence (VRPMPLQ), which was
conjugated with fluorescein and tested in patients undergoing
colonoscopy. The fluorescein-conjugated peptide was adminis-
tered topically and was found to bind more strongly to dysplastic
cells than to adjacent normal cells with 81% sensitivity and 82%
specificity.
Fluorescein isothiocyanate (FITC)-labeled anti-EGFR antibody
and CLE were used to perform fluorescence targeting in mice
with subcutaneous grafts of human colorectal cancer and in 15
endoscopic/surgical specimens of human colon tissue (six of
them neoplastic) incubated in labeled EGFR antibody solution
[10]. In the animal model, 45 minutes after injection of the anti-
bodies, a specific fluorescent signal from the tumor was observed
in vivo when a handheld rigid confocal probe (Optiscan, Notting
Hill, Victoria, Australia) was placed in contact with the tissue
with an excitation wavelength of 488nm and a detection band
range of 505 to 585nm. Interference from baseline tissue auto-
fluorescence and nonspecific antibody binding was excluded by
imaging the tumor before injection of the antibodies and after in-
jection of a negative control. In the unfixed human tissue speci-
mens, confocal imaging was performed mainly with the hand-
held probe and in two cases with a confocal endomicroscope
(Pentax, Tokyo, Japan), which have characteristics in common.
CLE analysis of EGFR expression, with histopathology used as
the gold standard to classify the specimens, showed a statistically
significant contrast (P=0.0035) between neoplastic and non-
neoplastic tissues, although weak fluorescence was also found
in two samples of ischemia.
A similar study was performed by the same group [46] in ApcMin
mice, xenograft models, and surgical specimens of patients with
colorectal cancer. A vascular endothelial growth factor (VEGF)-
specific signal was visualized in vivo in 13 of 15 ApcMin mice, in
9 of 10 xenograft tumors, in 12 of 13 neoplastic specimens, and in
10 of 11 normal samples collected from patients during endos-
copy. Both these studies advanced the concept of the feasibility
of endoscopic molecular imaging in vivo.
Recently, AFI and a fluorescently labeled lectin, Tritiicum vulgare
agglutinin (WGA), have been used to detect changes in glycan ex-
pression on the epithelial cell surface associated with the transi-
tion from Barrett’s esophagus through dysplasia to adenocarcino-
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ma [47]. In particular, AFI was used to imageWGA in four esopha-
gectomy specimens obtained immediately after surgery. The spe-
cimens were intubated from the proximal end, and both white
light and autofluorescence images were acquired at baseline.
Fluorescein-labeled WGA was sprayed over the esophageal mu-
cosa and imaged with 395- to 475-nm excitation. Specimens
were then opened along their vertical axis and imaged with an
IVIS camera (Caliper Life Sciences, Hopkinton, Massachusetts,
USA) to enable the quantification of fluorescence and registration
with histology. A highly significant statistical correlation be-
tween WGA fluorescence and degree of dysplasia was found (P=
0.0002), with areas of high grade dysplasia and cancer showing
lower fluorescence intensity and WGA binding relative to areas
of nondysplastic Barrett’s esophagus and normal esophageal mu-
cosa.
The toxicity of molecular probes is a critical point to consider
when molecular imaging is translated into the clinical setting.
This issue could significantly impair and limit the clinical applica-
tion of the method in vivo. Using concentrations below those
known or shown to cause toxicity in animal models and for
shorter periods of time is therefore paramount. Another point to
consider is the way to deliver these agents. Local application
through the endoscope, as in the study by Bird-Lieberman et al.
[47], would be preferable to a systemic delivery method. Consid-
erable research is currently under way to develop innovative
nontoxic or less phototoxic drugs and delivery mechanisms for
fluorescently labeled probes.
Techniques for spatial resolution enhancement
!
Optical coherence tomography
OCT is the optical equivalent of ultrasound imaging, in which ul-
trasound waves are replaced by light. As with endoscopic ultra-
sound (EUS), two main types of OCT are available – linear and ra-
dial.
The basic components of an OCT system are a low coherence light
source and a beam splitter, which splits the light into two identi-
cal beams, one directed to the tissue and the other to a mirror. An
interferometer is used to combine the signals coming back from
the tissue and the mirror; following signal-processing steps,
cross-sectional images are obtained. Contrast in OCT is essential-
ly due to reflected or simply backscattered light from refractive
index mismatches within tissue.
OCT is a high speed (approximately 4 frames per second [48])
vertical plane imaging modality that combines confocal scanning
capability with low coherence interferometry, resulting in excel-
lent rejection of scattered light and deep tissue penetration. The
use of near-infrared light (from approximately 800 to 2500nm)
allows OCT to penetrate into scattering media more deeply (up
to 4mm, depending on tissue type) than confocal microscopy,
with typical lateral resolution of 15μm and axial resolution of
10μm, although research systems have demonstrated axial reso-
lution on the order of 1μm [48].
Clinical experience
Optical discrimination of the gastrointestinal tissue layers was
first described in a landmark paper by Tearney et al. [49], who
collected normal and diseased tissues and imaged them with
OCT. Exploratory in vivo studies by Jackle et al., using portable
OCT equipment and a fiberoptic flexible probe during routine
endoscopic procedures, showed distinct OCT patterns in the mu-
cosal structure of normal esophagus, reflux esophagitis, Barrett’s
esophagus and Barrett’s esophagus-related adenocarcinoma [50],
and colonic adenoma and adenocarcinoma [51]. Subsequently,
Zuccaro et al. [52] showed that OCT could discriminate normal
esophageal mucosa from cancer (both adenocarcinoma and
squamous cell carcinoma).
Other studies further characterized differences in the structure of
normal colon, adenomatous polyps, and hyperplastic polyps,
with dysplasia outlined by a loss of tissue organization and re-
duced light scattering [53], and in the OCT patterns of normal co-
lon, radiation proctitis, and adenocarcinoma [54]. OCT has been
used in the detection of dysplasia in Barrett’s esophagus. Modest
sensitivity and specificity were reported in a prospective double-
blind study using a dual-channel endoscope (68%, 82%) [55], and
in a study using an OCT image scoring system based on consensus
histopathological diagnoses in the detection of high grade dys-
plasia and intramucosal carcinoma (83%, 75%) [56]. The role of
endoscopic OCT in unmasking buried glands in Barrett’s esopha-
gus before and after radiofrequency ablation has also been de-
scribed [57,58].
This novel technique clearly has the intrinsic potential to reach
the muscularis mucosae and thus discriminate noninvasive from
invasive neoplasia. In a comparative study in normal tissue, Das
et al. [59] showed that OCT has a higher resolution than high fre-
quency (20–30MHz) EUS for imaging this layer with accuracy.
Accurate delineation of the muscularis mucosae would in fact as-
sist clinicians in determining whether endoscopic therapy rather
than surgery should be recommended. In vivo endoscopic OCT
was also used to assess the efficacy of radiofrequency ablation in
treating persistent rectal bleeding from radiation proctitis unre-
sponsive to conventional therapy [60].
A form of OCT, termed comprehensive volumetric microscopy,
has been proposed that acquires a three-dimensional micro-
scopic image of the full thickness of the distal esophagus [31,
32]. In a preliminary study by Suter et al. [61], volumetric micro-
scopy of the distal esophagus was performed in 66 patients re-
ferred for Barrett’s esophagus screening with a custom balloon
catheter (2.5cm in diameter) that enabled spiral cross-sectional
optical frequency domain imaging, a high speed second-genera-
tion embodiment of OCT. With histopathology used as the gold
standard, optical frequency domain imaging showed increased
sensitivity for the detection of specialized intestinal metaplasia
in comparison with standard endoscopy.
Columnar epithelium and squamous epithelium in a region of
heterotopic gastric mucosa (cervical inlet patch) in the upper
esophagus were clearly distinguished when a through-the-scope
three-dimensional OCT prototype probe was used. En face ima-
ges were acquired to a depth of 400µm below the tissue surface
and were compared with histology. The examination of biopsy
specimens taken from the imaged lesion confirmed the endo-
scopic finding [62].
Two-photon and multi-photon microscopy
Biological tissues are, of course, inherently three-dimensional
and typically have a high degree of scattering due to discontinu-
ities in the refractive index and the heterogeneity of their consti-
tuents, which make high resolution three-dimensional imaging
challenging.
Optically sectioned fluorescence imaging can be realized with
single-photon confocal (visible light) or multi-photon excitation.
In multi-photon microscopy (MPM), the excitation occurs
through the absorption of multiple photons of lower energy (ty-
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pically halved in two-photonmicroscopy). No pinhole is required
to prevent out-of-focus fluorescence from reaching the detector
because excitation occurs only at the excitation spot. However,
high incident power is required for multi-photon absorption to
take place.
A major advantage of MPM is the longer wavelength of the light
necessary to induce fluorescence (generally near-infrared, 700–
1000nm). Tissue absorption and scattering are limitedwith near-
infrared, allowing deep penetration imaging. A number of groups
have developed miniaturized multi-photon microscopy endo-
scopes [63–65]. However, no commercially available multi-pho-
ton endoscope system is available to date.
Rivera et al. [66] demonstrated a compact flexible raster scanning
microendoscope capable of MPM and second harmonic genera-
tion by imaging mouse tissue ex vivo at 800-nm excitation. Ima-
ges were acquired at 4.1 frames per secondwith a field of view of
110×110μm when a double-clad fiber and a mode-locked Ti:
sapphire laser were used as the excitation source. The distal end
of the fiber was mounted onto a resonant/nonresonant scanner,
which moved the fiber tip in a raster pattern across the back
aperture of a miniaturized gradient index lens assembly, en-
abling two-dimensional lateral scanning.
In normal colon specimens excited at 735nm with MPM, peak
fluorescence emission intensity in the 410- to 490-nm wave-
length range has been reported [67]. It was suggested that this
fluorescence at relatively longer wavelengths could be attributed
to flavins and possibly lipofuscin, which are respectively found in
cells within the interstitial space and leukocytes within the lami-
na propria.
In a study of freshly excised gastrointestinal tissue from 10 nor-
mal and 5 transgenic mice, excitation spectral signatures of epi-
thelium, lamina propria, collagen, and lymphatic tissue were de-
termined by using hyperspectral two-photon microscopy with
740-nm excitation and three emission channels (350–505nm,
505–560nm, and 560–650nm). Based on the three-dimensional
sectioned two-photon images acquired, the morphology of these
four main components was clearly visualized and compared with
cross-sectional histology with a high degree of concordance [68].
Using MPM at 800-nm excitation, Zhuo et al. [69] performed a
quantitative analysis of the redox ratio reduced nicotinamide
adenine dinucleotide (NADH)/flavin adenine dinucleotide (FAD)
to quantitatively monitor colonic cancer progression. The redox
ratio was shown to increase with progression from dysplasia to
cancer.
In a recent video and article from Schurmann et al. [70], fresh
samples collected during endoscopy from controls and patients
with IBD within 3 hours of excision were analyzed with single-
color and multicolor imaging and spectral separation (395–
415nm/435–465nm/540–580nm) at 800-nm excitation. MPM
made it possible to observe and compare tissue morphology in
normal and inflamed specimens (from different patients) and
to attribute the fluorescent signals detected to the different
structures presumably identified (e.g., basal membrane, epithe-
lial cells, and interstitial cells in the lamina propria). However,
no statistically significant changes were reported, the normal
interpatient variability was not characterized, and the correla-
tion between fluorescent signals and tissue fluorophores and
structures appeared to be too simplistic.
Second and third harmonic generation imaging
Like MPM, second harmonic generation (SHG) and third harmo-
nic generation (THG) imaging depend on the simultaneous inter-
action of two or three photons with the tissue under investiga-
tion. A long excitation wavelength, typically in the near-infrared
range, is required for these phenomena to take place. However,
whereas in MPM two photons are absorbed to produce a single
fluorescent photon, in SHG and THG the photons are scattered,
not absorbed by the tissue, to produce a new photon with two
(SHG) or three (THG) times the energy of the incident photons.
With these techniques, because of the absence of absorption,
heating and damage of the sample are less likely to occur. An-
other advantage is the potential for three-dimensional imaging.
SHG techniques allow the imaging of “non-centrosymmetric”
structures, such as collagen, with reported tissue penetration
depths between 100 and 300μm at laser excitation in the near-
infrared range. Therefore, they have been increasingly applied to
characterize the structural changes occurring in the extracellular
matrix during disease. An example is the desmoplastic reaction
that typically accompanies the progression of many cancers.
Using SHG microscopy at 800-nm excitation, Zhuo et al. [71] im-
aged 72 fresh colonic biopsy specimens from 32 patients and
were able to quantify significant changes in the circle length of
the crypt basement membranes (from en face SHG images) of
normal, precancerous, and cancerous colonic tissues. Another
important potential application of SHG microscopy is imaging fi-
brosis in liver and IBD.
Coherent anti-Stokes Raman scattering microscopy
Based on contrast derived from molecular vibration, CARS has
the potential to provide fast imaging on a molecular level that is
label free and has three-dimensional sectioning capability. Un-
like Raman spectroscopy, CARS employs multiple photons to
probe the molecular vibrations and produces a signal in which
the emitted waves are coherent with one another. As a result,
the CARS signal is orders of magnitude stronger than sponta-
neous Raman emission and so can provide much faster imaging.
A detailed comparison of Raman imaging and CARS microscopy
was carried out by Krafft et al. [72] in ex vivo colon tissue sec-
tions, raising the intriguing prospect of a combined complemen-
tary method for label-free live-cell imaging at video-rate speed,
which is ideal for most clinical applications. Although prototype
endoscopes capable of collecting CARS signals have been devel-
oped [73,74], progress in delivering in vivo CARS imaging in gas-
trointestinal endoscopy is still awaited.
Summary
!
Recent advances in gastrointestinal endoscopy constitute an un-
precedented leap forward in basic and clinical research for both
patients and clinicians. In theory, these advancements offer the
yearned-for possibility of increasing the rates of detection of
high risk lesions and the ability to target biopsies and resections,
and so reduce the need for biopsy, costs, and uncertainty for both
patients and clinicians. However, there appear to be two separate
research communities, one working with sophisticated endo-
scopic technology and the other with disease biomarkers, func-
tioning independently. It would seem sensible to integrate these
two approaches to identify risk predictors and determine which
modality is best for each patient population. All the emerging
biophotonic techniques in endoscopy, with their pros and cons
and clinical experience to date, are summarized in●" Table1.
It is still unknownwhich technique or combination of techniques
offers the best potential. The optimal method will probably have
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the ability to survey wide areas of tissue in concert with the abil-
ity to obtain the necessary degree of detailed information provid-
ed by point measurements. This would be made possible by cou-
pling a wide-field modality to a mode of single-point measure-
ment.
One optical technology potentially capable of meeting these re-
quirements is FLIM. Nevertheless, to date FLIM has been investi-
gated in the gastrointestinal tract only ex vivo in a relatively small
number of samples, and further studies are required to confirm
the initial findings. Systematic studies in vivo of the fluorescence
lifetime signatures in normal and diseased tissue are crucial for
acquiring a complete understanding of the origin of the auto-
fluorescence contrast observed, and for assessing the ability of
fluorescence lifetime technology to provide an accurate clinical
diagnosis.
Techniques such as MPM, SHG, and CARS have not yet made the
transition between research and in vivo clinical application.
However, the diagnostic morphologic-functional capability of
MPM is superlative, and in the near future this technique is likely
to be the winner.
Raman spectroscopy offers the exciting prospect of revealing
highly specific biochemical changes beforemorphologic differen-
ces between normal and diseased tissue become detectable.
However, it cannot be readily extended to provide a wide-field
screening tool that can image fields of view of several centime-
ters.
Among all the biophotonic techniques described in this review,
OCT is certainly themost mature. OCT has brought optical resolu-
tion down to a few microns, enabling for the first time three-di-
mensional tissue microscopy in vivo during endoscopy. However,
although of invaluable assistance for tissue characterization, this
technique can only infer structural aspects and does not provide
functional information about tissue. Thus, rather than in detec-
tion or screening, this technique may have a role in determining
prognosis and predicting treatment response.
Because of the highly accurate detection of early cytological
changes, DRS may have a role as a prescreening method before
conventional cancer screening endoscopy to rule out the pres-
ence of a field effect and therefore identify patients potentially
harboring neoplasia.
Lastly, molecular imaging represents the quintessence of the ap-
plication of biophotonics to endoscopy, in thatmolecular biomar-
kers and fluorescence detection are exploited for targeted diag-
nosis at the cellular and subcellular levels. In contrast with tissue
autofluorescence alone, in which the fluorescence signal is often
weak, labeled antibodies can provide highly specific contrast.
However, theymust be certified for human use, so that course as-
sessments for safety and pharmacokinetics are required, and this
clearly limits their immediate clinical utility.
Crucial to the clinical translation of all these techniques to endos-
copy is the development of compact and real-time systems that
are suitable for in vivo clinical applications. For instance, since
the end of the 1990s, several FLIM endoscope designs have been
proposed [75–82], and current efforts are directed to implement
and validate this technology for modern endoscopy.
In fluorescence-based techniques, the greatest technological bar-
rier to overcome is the background fluorescence from the fiber
probes. At the wavelengths typically used for autofluorescence
studies (310 and 420nm) [83,84], the fluorescence from the fi-
bers occurs over the whole length of the fiber bundle, is very
strong, and completely masks the fluorescence arising from the
area of tissue under investigation. The limit is fixed at 420nm,
the shortest excitation wavelength currently exploitable with
this implementation. One possible way to overcome the limita-
tion is to construct fiber prototypes with lower background
fluorescence so as to avoid the unwanted background fluores-
cence exhibited by the fiber bundle used to carry the excitation
light.
Another important limitation of these techniques is that it is not
known whether the proposed exposure to light (e.g., ultraviolet
A) delivered to the gastrointestinal mucosal epithelium during
endoscopy is safe. Strategies to overcome this limitation include
restricting the average optical power at the sample in order to
minimize the risk for tissue damage. There is currently no accep-
ted limit on the exposure of internal tissues to light. In the ab-
sence of a suitable standard, the International Commission on
Non-Ionizing Radiation Protection (ICNIRP) guidelines regarding
skin exposure are the most appropriate ones to follow. Irradiance
at power levels lower than the maximum permissible exposure
(MPE) for skin is therefore recommended at present. Previous
work in the literature indicates that these levels of exposure
caused no increase in triphosphate-biotin nick end-labeling
(TUNEL)-positive cells above baseline compared with controls in
porcine esophagus and colon [85]. However, further studies of
phototoxicity and in vivo applications are required to identify
the most discriminating wavelengths and lifetimes in order to
create a relevant diagnostic model to demonstrate performance.
Other challenges are the following: (i) to develop suitable com-
pact, portable systems that can be housed in a way that is appro-
priate for clinical use, allowing them to be easily sterilized and
transported; (ii) to develop software tools for the analysis and in-
terpretation of data; and (iii) to apply the instrumentation to pa-
tients. Essential for the transition of photonic approaches into
clinical diagnostics is therefore the contribution of clinicians in
designing, guiding, and assessing the specification, sterilization,
ethical approval, and clinical use of these techniques.
Whether these techniques will soon be useful in clinical practice
is still under investigation. Further validation studies are urgent-
ly awaited, and several groups worldwide are currently working
toward this milestone.
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